Archive for the 'Genentech' Category

Genentech news feed.

Success in Lung Cancer Treatment Gives Hope to Mesothelioma Patients

The latest success concerning a treatment for non- small cell lung cancer (NSCLC) has scientists and researchers hopeful that the same treatment can be applied to mesothelioma victims. The Phase III trial for Alecensa (alectinib), while currently not recruiting participants, is on-going and results thus far have shown to be promising for those with NSCLC.


FDA Approves Avastin, A Targeted Therapy for First-Line Metastatic Colorectal Cancer Patients; First Anti-Angiogenesis Treatment Approved for Treating Cancer

Related News 2 drugs open a new front in cancer war: Avastin, Erbitux herald revolution that targets cells (free membership required) – March 2, 2004 (Judy Peres, Chicago Tribune). QUOTE:“‘We’re in a new era of drug development for cancer,’ said Dr. Hedy Kindler, director of gastrointestinal oncology at the University of Chicago who has tested


Last update: April 01, 2019. 03:30:08 pm.